Home DR Healthcare

[rev_slider alias=”home-031″]

Focused on chronic and under-treated diseases.

New generation of dietary foods.

We already have more than 80 patents and international marketing licenses.

DR Healthcare has launched an awareness campaign on DAO Deficiency under the title ME AGAIN. In it, four siblings discover that the different symptoms that affect them: migraine, fibromyalgia, digestive disorders, atopic skin and ADHD (in the son of one of them), may have a common genetic origin in DAO Deficiency.

You can access the videos and the content of the campaign by clicking on the following button.

DR Healthcare

We are a Biomedical Company specialized in Medical Nutrition.

Founded in 2007 in Barcelona, we manufacture, research, develop, innovate, market and carry out licensing -out of new nutraceutical products, functional foods, active ingredients and customized solutions.

Our great value is research and we firmly believe in the “Enterprise-University” alliance, developing our activities in two R&D centers.

DR Healthcare is a business unit de AB Biotek. For more information access to www.abbiotek.com.

Nutraceuticals and diagnosis

From our production plant we offer our nutraceutical products in different gastro-resistant formats (tablets, pellets, micropellets, capsules, microcapsules and nanocapsules), facilitating the adaptation to the current regulation of each market and its commercialization at international level.

We also develop In Vitro molecular diagnostic kits for DAO activity.

Manufacturing for third parties

DR Healthcare manufactures and markets the active substance (Diamine Oxidase – DAO enzyme) for third parties, both for human and animal use.

We make available to pharmaceutical and food companies that are looking for a reliable supplier, the highest levels of quality, regulatory support and production of Diamine Oxidase, manufactured in our enzyme production plant located in Tarragona (Spain).

The production of this ADI (Active Dietary Ingredient) is vertically integrated so it is able to control the intermediates of its manufacturing.

Customized solutions

DR Healthcare stands out as a leading company in the production of Diamino Oxidasa, which allows us to offer tailored solutions for use in the veterinary, animal health and food sectors.

Our solutions based on Diamino Oxidase are adapted to the new food control standards, which stipulate the control of histamine levels in order to avoid risks of poisoning due to the consumption of large amounts of this biogenic amine present in food.

Veterinary and animal health sector

Veterinary solutions based on Diamino Oxidase for the dietary management of histaminosis and DAO deficiency in domestic animals, livestock and aquaculture. Its health is that of all being vital to control the pathophysiological effects that trigger high levels of histamine.

Food industry sector

FAO and WHO and countries around the world have applied regulations that include the analysis of foods that may contain high levels of histamine and measures to prevent their production through proper conservation, processing and distribution.

DAO deficiency specialists

DAO deficiency is an alteration in the metabolism of food histamine that occurs when there is little activity of the enzyme Diamino Oxidase (DAO). DAO is the main enzyme in the metabolism of exogenous histamine and develops its functional activity in the intestine.

Since there is a disproportion between the histamine ingested or released by the cells that store it in the body, and the ability to metabolize it, the accumulation of histamine in plasma and the appearance of adverse effects occurs.

Main symptoms of DAO deficiency

Migraine, fibromyalgia, irritable bowel syndrome (SCI) and attention deficit hyperactivity disorder (ADHD) are the symptoms with the highest prevalence in the population caused by DAO deficiency.

Actuality

Press releases and media’s news

New Regulatory Approvals Support DAO Deficiency Solution Expansion

16 March, 2022

In February 2022, the active ingredient diamine oxidase – or DAO – produced by AB Biotek’s DR Healthcare division, as well as the solutions derived from it, have obtained the GRAS (Generally Recognized As Safe, per sections 201(s) and 409 of the U.S. Food & Drug Act) qualification from the U.S. Food & Drug Administration. This allows for the upcoming...

1
2
3
4
5
6

Scientific and clinical evidence in DAO deficiency

Serum Diamine Oxidase Values, Indicating Histamine Intolerance, Influence Lactose Tolerance

12 May, 2022

Download the paper clicking here Abstract: Lactose intolerance (LIT) is one of the major causes of irritable bowel syndrome (IBS) spectrum complaints. Differences in inadequate lactose digestion are described as various LIT phenotypes with basically unknown pathophysiology. In LIT patients, we retrospectively assessed the effect of histamine intolerance (HIT)...

1
2
3
4
5
6

Blog

Not only does the coronavirus alter Christmas

24 December, 2020

The Coronavirus has altered our lives. And it will also alter this Christmas, which will undoubtedly be different. Still, some things are not going to change compared to the Christmas holidays of other years: emotions increase, alcohol is exceeded, meals are exaggerated and, consequently, many people will have heavy digestion, flatulence, a feeling of bloating,...

1
2
3
4
5

Activities and events

TRAINING ACTIVITY “DAO DEFICIENCY AND THE ROLE OF THE PHARMACIST IN THE DIAGNOSIS AND TREATMENT”

30 May, 2019

Next Monday 17 June (2019), will take place from 14.00 to 16.00 hours in the University Rovira i Virgili (Edifici N5 Sustainable Chemistry, Assembly Hall.Marcel.li Sunday, 2-4-6, Sescelades Campus 43007-Tarragona, Spain) the training activity “DAO deficiency and the role of the pharmacist in the diagnosis and treatment” (language: Spanish). This training is organized...

1
2
3
4
5
6

St/Escoles Píes, 49, 08017

DR HEALTHCARE ESPAÑA, S.L. (Barcelona, Spain)